Phospho-Energon

Last updated

Energon logo Energonadvert.png
Energon logo
Phospho-Energon-Piller, "med jarn och arsenik" (with iron and arsenic), box of 300 pills, marketed by A.-B. Pharmacia Phospho-Energon-Piller, MED JARN OCH ARSENIK, A.-B. PHARMACIA, STOCKHOLM, product box detail, from- Energon ask (cropped).jpg
Phospho-Energon-Piller, "med järn och arsenik" (with iron and arsenic), box of 300 pills, marketed by A.-B. Pharmacia

Phospho-Energon, often just called Energon, was a "miracle medicine" produced and distributed in Sweden. With the incomes generated by the Energon sales, the emerging Swedish pharmaceutical company Pharmacia (founded in 1911 out of the Elgen pharmacy in central Stockholm) was able to establish itself in the market and begin pharmaceutical research and the production of other medicines, eventually becoming a major actor in the Swedish and international pharmaceutical sectors.

The main ingredients of Energon were calf's brain, sugar, and milk. [1] [2] Initially, the drug was sold as a powder to be mixed with liquid, but later pills were produced.

The product was said to have a "safe and rapid effect against general debility, lack of appetite, nervous tension, exhaustion, and sleeping problems". The drug was also used against blood deficiency and disturbances in the neural system. [3] Moreover, the advertisement of Pharmacia claimed that consumption of Energon would relieve the user of fear of traffic, through the soothing of the nerves. [4]

In early advertisements, Pharmacia claimed that the drug was endorsed by Swedish physicians. Moreover, the company stressed that its production was conducted under the scrutiny of professor Karl Albert Vesterberg  [ sv ]. [3]

The permit to sell the Phospho-Energon pills in Swedish pharmacies lapsed in 1936. [5] The permits to sell four variations of the Phospho-Energon pills (with arsenic, iron and kola extracts) in Swedish pharmacies lapsed in 1943. [6]

The preparation Phospho-Energon with kola contained the following ingredients: [7]

Dried cow brain; Dried kola extract; Ferrous tartrate; Calcium pantothenate; Choline; Copper sulphate; Licorice; Nicotinamide; Pyridoxine; Riboflavin; Thiamine

Related Research Articles

<span class="mw-page-title-main">Pharmacia</span> Pharmaceutical and biotechnological company

Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in 1995.

<span class="mw-page-title-main">Penciclovir</span> Chemical compound

Penciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections. It is a nucleoside analogue which exhibits low toxicity and good selectivity. Because penciclovir is absorbed poorly when given orally it is more often used as a topical treatment. It is the active ingredient in the cold sore medications Denavir, Vectavir and Fenivir. Famciclovir is a prodrug of penciclovir with improved oral bioavailability.

<span class="mw-page-title-main">AL-LAD</span> Chemical compound (psychedelic drug)

AL-LAD, also known as 6-allyl-6-nor-LSD, is a psychedelic drug and an analog of lysergic acid diethylamide (LSD). It is described by Alexander Shulgin in the book TiHKAL. It is synthesized starting from nor-LSD as a precursor, using allyl bromide as a reactant.

Astra AB was a former international pharmaceutical company headquartered in Södertälje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca. Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control. At the time of the fusion, Astra was the largest Swedish pharmaceutical company. Astra also operated Astra Tech, a medical devices company, and marketed pharmaceuticals outside their primary development area, including anti-infective agents.

<span class="mw-page-title-main">Compounding</span> Preparation of a custom medication

In the field of pharmacy, compounding is preparation of a custom formulation of a medication to fit a unique need of a patient that cannot be met with commercially available products. This may be done for medical reasons, such as administration in a different format, to avoid a non-active ingredient the patient is allergic to, or to provide an exact dose that isn't commercially available. Medically necessary compounding is referred to as "traditional" compounding. It may also be done for medically optional reasons, such as preference of flavor or texture, or dietary restrictions.

<span class="mw-page-title-main">Trollhättan–Vänersborg Airport</span> Airport in on the border between Trollhättan and Vänersborg

Trollhättan–Vänersborg Airport is a small regional airport situated outside Trollhättan, Sweden. Braathens Regional Airlines (BRA) has its corporate head office on the airport property.

<span class="mw-page-title-main">Bellevue Mosque</span> Mosque in Gothenburg, Västra Götaland, Sweden

The Bellevue Mosque is a mosque in Gothenburg, Sweden. It is located at Generalsgatan 2A in the "Bellevue" district of Gothenburg. The mosque is administered by the Somali-dominated Islamic Sunni Centre Denomination and advocates the Salafi movement of Islam. It was created with funds from Saudi Arabia.

<span class="mw-page-title-main">Medical Products Agency (Sweden)</span>

The Medical Products Agency is the government agency in Sweden responsible for regulation and surveillance of the development, manufacturing and sale of medicinal drugs, medical devices and cosmetics.

Socialdemocrats for Faith and Solidarity, formerly the Swedish Association of Christian Social Democrats organizes religious members of the Swedish Social Democratic Party. The organization was founded in 1929 as an organization for Christian social democrats. Since 2011, it has been open for members of all religions. It is an associate member of the International League of Religious Socialists.

Fuat Deniz was a Swedish sociologist and writer of Assyrian descent. Until his murder in 2007, he worked as a lecturer in sociology at the Department of Social and Political Sciences at Örebro University.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

<span class="mw-page-title-main">Tommy Möller</span> Swedish political scientist

Tommy Möller is a Swedish professor of Political science at Stockholm University, and a frequent conservative political commentator in the Swedish media.

<span class="mw-page-title-main">25I-NBF</span> Chemical compound

25I-NBF is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a highly potent partial agonist for the human 5-HT2A receptor, with bias towards the β-arrestin 2 coupled signalling pathway. It has been studied in its 11C radiolabelled form as a potential ligand for mapping the distribution of 5-HT2A receptors in the brain, using positron emission tomography (PET).

Eva Maria Meyersson Milgrom is a Swedish-born American social scientist publishing both in economic and sociology academic journals. She received her Ph.D. from the Department of Sociology at Stockholm University in 1992.

<span class="mw-page-title-main">Cannabis in Sweden</span> Use of cannabis in Sweden

Cannabis in Sweden is illegal for all purposes. It is illegal for recreational purposes, for most medical purposes and possession of even small amounts of cannabis is a criminal offence. Consequently, limited medical usage of cannabis-based drugs is only allowed for specific conditions.

Vulnerable area is a term applied by the Swedish Police Authority to areas with high crime rates and social exclusion. In the December 2015 report, these areas numbered 53. In the June 2017 report, these totalled 61. The increase is reported to be due to better reporting, not a changing situation. The overall trend is that these areas are improving.

<span class="mw-page-title-main">Kronans Apotek</span> Swedish pharmacy chain

Kronans Droghandel Apotek AB, doing business as Kronans Apotek, is a Swedish pharmacy company. The pharmacy chain is owned by the Finnish company Oriola Oyj-KD, which is listed on the Helsinki Stock Exchange. Kronans Apotek has 326 pharmacies across Sweden, and over 65,000 customer visits per day.

<span class="mw-page-title-main">COVID-19 vaccination in Sweden</span> Plan to immunize against COVID-19

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people in Sweden have received at least one dose, with a total of 21,491,717 doses administered. At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated.

Yrjö Wilhelm Jalander was a Finnish pharmacist and the founder of Oy Merijal Ab and the pharmaceutical factory Leon.

References

  1. ""Vad är egentligen ett läkemedel?" - Läkemedelsvärlden - Oberoende om läkemedel". Archived from the original on 21 August 2010. Retrieved 6 August 2008.
  2. "Nyponextrakt, tuggummi och fusioner - Läkemedelsvärlden - Oberoende om läkemedel". Archived from the original on 26 August 2010. Retrieved 6 August 2008.
  3. 1 2 "Archived copy" (PDF). Archived from the original (PDF) on 20 July 2011. Retrieved 6 August 2008.{{cite web}}: CS1 maint: archived copy as title (link)
  4. "Archived copy". Archived from the original on 12 June 2007. Retrieved 6 August 2008.{{cite web}}: CS1 maint: archived copy as title (link)
  5. "Läkemedelsverket: Upphörande av godkännande för försäljning av läkemedelsprodukter mellan 1900-01-01 och 1939-12-31" (PDF). Archived from the original (PDF) on 22 July 2011.
  6. "Läkemedelsverket: Upphörande av godkännande för försäljning av läkemedelsprodukter mellan 1940-01-01 och 1959-12-31" (PDF). Archived from the original (PDF) on 22 July 2011.
  7. "Phospho-energon med kolaextrakt - FASS Vårdpersonal". www.fass.se. Archived from the original on 8 March 2016. Retrieved 10 January 2021.